Breakthrough trial aims to slash Drug-Resistant TB treatment time
NCT ID NCT06441006
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study tests whether a shorter, personalized treatment plan (called BPaLM) works as well as the standard longer treatment for people with a type of drug-resistant tuberculosis (TB). About 400 adults with fluoroquinolone-susceptible multidrug-resistant TB will be randomly assigned to different treatment lengths (13 to 24 weeks) to find the best balance of curing the disease and reducing side effects. The goal is to make treatment faster and more tolerable without losing effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS, PULMONARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hanoi Lung Hospital
NOT_YET_RECRUITINGHanoi, Vietnam
Contact
Contact
-
Hospital Nacional Sergio E. Bernales
NOT_YET_RECRUITINGLima, Peru
Contact
Contact
-
Institute of Chest Diseases
NOT_YET_RECRUITINGKotri, Pakistan
Contact
-
Mulago National Referral Hospital
NOT_YET_RECRUITINGKampala, Uganda
Contact
-
National Center for Communicable Diseases
RECRUITINGUlaanbaatar, Mongolia
Contact
-
Policlínico SES
NOT_YET_RECRUITINGLima, Peru
Contact
Contact
Conditions
Explore the condition pages connected to this study.